Spectral AI, Inc.

Spectral AI, Inc. (Nasdaq: MDAI) is a healthcare technology company developing artificial intelligence tools for acute wound care diagnostics, primarily through its DeepView imaging platform, which applies machine-learning models to assess burn wound depth and guide clinical triage decisions at the point of care. The company is currently publicly traded on Nasdaq following a SPAC business combination, operating in the medical AI and digital health sector. On January 23, 2024, Spectral AI filed an S-1/A registration statement amendment with the SEC, updating its post-merger public disclosures. To explore full SPAC deal data, filing history, and company coverage for MDAI, sign up for access on SpacDesk today.